Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.
https://www.cancer.fr/catalogue-des-publications/inhibiteurs-de-parp-olaparib-niraparib-rucaparib-talazoparib 2022 false false false France practice guideline talazoparib olaparib Poly(ADP-ribose) Polymerase Inhibitors talazoparib rucaparib olaparib niraparib niraparib olaparib rucaparib
--- https://www.cochrane.org/fr/evidence/CD011395_parp-inhibitors-locally-advanced-or-metastatic-breast-cancer 2021 false false false France United Kingdom review of literature french abstract breast neoplasms breast cancer neoplasm, malignant Poly(ADP-ribose) Polymerase Inhibitors
--- https://www.ansm.sante.fr/actualites/lynparza-dans-les-cancers-gynecologiques-un-document-pour-guider-les-patientes-lors-du-passage-des-gelules-aux-comprimes 2020 false false false France French patients guideline guidelines for drug use olaparib Poly(ADP-ribose) Polymerase Inhibitors administration, oral genital neoplasms, female olaparib capsules tablets phthalazines piperazines
--- https://www.e-cancer.fr/content/download/277829/3943703/file/Inhibiteurs_PARP_preconisation_pour_un_parcours_en_genetique_oncologique_mel_20191104.pdf 2019 France guidelines genetics Oncologists Poly(ADP-ribose) Polymerase Inhibitors Genetics Genetics Genetics Oncology gene, nos
--- http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Cancer-de-l-ovaire-et-inhibiteur-de-PARP-parcours-des-patientes-en-genetique-oncologique 2017 false false false France French scientific and technical information ovarian neoplasms gene, nos genetics patients cancer neoplasm, malignant Poly(ADP-ribose) Polymerase Inhibitors oncologic ovary has patient neoplasms ovary
--- https://smf.swisshealthweb.ch/fr/article/doi/fms.2017.03056/ 2017 false false false Switzerland French practice guideline ovary patients cancer Poly(ADP-ribose) Polymerase Inhibitors ovarian neoplasms neoplasm, malignant has patient involved ovary neoplasms